After observing that CC10 deficiency exacerbates antigen-induced allergic airway inflammation, we explored the therapeutic potential of exogenous CC10 protein in mitigating inflammation in HDM-induced asthma models. This evidence concerns the gene SCGB1A1 and asthma.